Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-24T07:36:25.425Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Characteristics of the First 100 Patients of COVID-19 in Tobruk, Libya: A Brief Report From Low-Resource Settings

Published online by Cambridge University Press:  19 April 2021

Faisal Ismail Open the ORCID record for Faisal Ismail [Opens in a new window] ,
Atiya Farag ,
Soghra Haq  and
Mohammad A. Kamal
Faisal Ismail*
Affiliation:
Clinical Laboratory Department, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya National Centre for Disease Control, Tobruk, Libya
Atiya Farag
Affiliation:
National Centre for Disease Control, Tobruk, Libya
Soghra Haq
Affiliation:
Clinical Laboratory Department, Faculty of Medical Technology, University of Tobruk, Tobruk, Libya
Mohammad A. Kamal
Affiliation:
West China School of Nursing/Institutes for Systems Genetics, Frontiers Science Centre for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia Enzymoics, Novel Global Community Educational Foundation, Australia
*
Corresponding author: Faisal Ismail, Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study aims to report the clinical features of a cohort of patients with suspected coronavirus disease (COVID-19) from Tobruk, Libya, and reflect upon the diagnosis challenge in low-resource settings.

Methods:

A descriptive report of the first 100 patients with suspected COVID-19 who have visited the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 screening clinic at the National Centre for Disease Control in Tobruk, Libya.

Results:

The most common presenting symptoms were fever (90%), cough (89%), dyspnea (85%), sore throat (79%), fatigue (78%), headache (64%), loss of smell (52%), loss of taste (53%), loss of appetite (43%), nausea and vomiting (26%), diarrhea (22%), and rhinorrhea (16%); 51% of the patients had lymphocytopenia, whereas 13% had thrombocytopenia. Bilateral infiltrates were the most common radiologic finding on chest X-ray (76%), and COVID-19 IgM and/or IgG antibodies were detected in 80% of the patients, whereas only 37% of the patients were tested positive by the reverse transcriptase polymerase chain reaction (RT-PCR).

Conclusions:

The disease continued its spread across the region. Fever, cough, and dyspnea were the main symptoms; 21% of the patients did not have any chest X-ray abnormalities. Initial negative results for either antibody testing or RT-PCR-testing for COVID-19 do not rule out the infection.

Keywords

chest X-rayCOVID-19laboratory findingsLibyarapid test antibodiesSARS-CoV-2
Type
Brief Report
Information
Disaster Medicine and Public Health Preparedness , Volume 16 , Issue 6 , December 2022 , pp. 2331 - 2334
Copyright
© Society for Disaster Medicine and Public Health, Inc. 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cucinotta, D, Vanelli, M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-160.Google ScholarPubMed
The National Centre of Disease Control of Libya. Country situation of COVID-19. 2006-2021. https://ncdc.org.ly/Ar/situation-of-corona/. Accessed February 18, 2021.Google Scholar
Guan, W-J, Ni, Z-Y, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.CrossRefGoogle ScholarPubMed
Goyal, P, Choi, JJ, Pinheiro, LC, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med. 2020;382(24):2372-2374.CrossRefGoogle ScholarPubMed
Sethuraman, N, Jeremiah, SS, Ryo, A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;323(22):2249-2251.CrossRefGoogle ScholarPubMed
Riccò, M, Ferraro, P, Gualerzi, G, et al. Point-of-care diagnostic tests for detecting SARS-CoV-2 antibodies: a systematic review and meta-analysis of real-world data. J Clin Med. 2020;9(5):1515.CrossRefGoogle ScholarPubMed
Kucirka, LM, Lauer, SA, Laeyendecker, O, et al. Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173(4):262-267.CrossRefGoogle ScholarPubMed
Wong, HYF, Lam, HYS, Fong, AH. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. 2020;296(2):E72-E78.Google Scholar
Ai, T, Yang, Z, Hou, H, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296(2):E32-E40.CrossRefGoogle Scholar
Elshazli, RM, Toraih, EA, Elgaml, A, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One. 2020;15(8):e0238160.CrossRefGoogle ScholarPubMed